Form 4: Jean M. Franchi Reports Acquisition of Restricted Stock Units and Stock Options in Biodesix Inc.
SEC Form 4 Filing
Director Jean M. Franchi reports the acquisition of restricted stock units and stock options in Biodesix Inc. on May 21, 2024.
Summary
- Jean M. Franchi, a director of Biodesix Inc. (BDSX), filed a Form 4 on May 23, 2024, reporting changes in beneficial ownership.
- On May 21, 2024, Franchi acquired 60,766 restricted stock units (RSUs) and 37,050 stock options.
- The RSUs will vest in full on March 31, 2025, subject to continued service with the Issuer, and have no expiration date.
- If service terminates other than for cause, the RSUs will vest on a prorated basis.
- The stock options, with an exercise price of $1.57, also vest in full on March 31, 2025, subject to continued service.
- Similar to the RSUs, prorated vesting applies if service terminates other than for cause.
- The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. It's a neutral-positive signal.
Positives
- The acquisition of RSUs and stock options aligns the director's interests with the company's performance.
- The vesting schedule encourages continued service and commitment to Biodesix.
- The prorated vesting terms provide some benefit even if service is terminated under certain circumstances.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders may view the granting of RSUs and stock options as a positive sign, aligning management's interests with company performance.
- Employees may see this as a positive sign of company stability and commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: acquisition of restricted stock units and stock options. |
| 05/23/2024 | Date of Form 4 filing. |
| 03/31/2025 | Vesting date for both restricted stock units and stock options. |
| 05/20/2034 | Expiration date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.